Clinical Trial Update: Paclitaxel and TAK-228 in Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of paclitaxel and TAK-228 in metastatic urothelial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• TAK-228

Snippet

Sponsor: Associació per a la Recerca Oncologica, Spain | Conditions: Metastatic Urothelial Cancer | Phase 2 | Status: UNKNOWN